Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations

Diabetic kidney disease (DKD) affects approximately one-third of patients with diabetes and taking into consideration the high cardiovascular risk burden associated to this condition a multifactorial therapeutic approach is traditionally recommended, in which glucose and blood pressure control play...

Descripción completa

Detalles Bibliográficos
Autores principales: Leoncini, Giovanna, Viazzi, Francesca, De Cosmo, Salvatore, Russo, Giuseppina, Fioretto, Paola, Pontremoli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557495/
https://www.ncbi.nlm.nih.gov/pubmed/32681470
http://dx.doi.org/10.1007/s40620-020-00803-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557495/
https://www.ncbi.nlm.nih.gov/pubmed/32681470
http://dx.doi.org/10.1007/s40620-020-00803-3

Ejemplares similares